Antidepressant adult suicidality committee
FDA's Psychopharmacologic Drugs Advisory Committee will discuss the results of ongoing FDA meta-analyses of suicidality data from adult antidepressant trials during a Dec. 13 meeting. The panel, along with FDA's Pediatric Advisory Committee, reviewed data concerning the relationship between antidepressants and suicidal thoughts and actions in children and adolescents during two 2004 meetings (1"The Pink Sheet" Sept. 20, 2004, p. 3). The meeting will be held at the Hilton in Silver Spring, Md., beginning at 8 a.m....
You may also be interested in...
FDA will require stronger warnings on antidepressants regarding the risk of pediatric suicidality following a Sept. 13-14 advisory committee review of the issue, but the agency is not yet ready to say that a "black box" will be necessary
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.